Saied Shemiranei, MD
General Practice · San Juan, PRNPI 1871951970
Payments from drug & device makers
Across 101 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$793
- Novo Nordisk$507
- Lilly USA, LLC$445
- Lucid Diagnostics Inc.$376
- Alkermes, Inc.$248
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,711100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $1,167 |
| AstraZeneca | 12 | $793 |
| Novo Nordisk | 11 | $507 |
| Lilly USA, LLC | 11 | $445 |
| Lucid Diagnostics Inc. | 5 | $376 |
| Alkermes, Inc. | 7 | $248 |
| Indivior Inc. | 6 | $219 |
| Gilead | 7 | $180 |
| Verity Pharmaceuticals Inc. | 2 | $176 |
| Amgen | 2 | $135 |
| Janssen Products, LP | 1 | $117 |
| Boehringer Ingelheim | 2 | $106 |
| Scilex Pharmaceuticals Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Bioventus LLC | 1 | $27 |
| Atland Pharmaceuticals, LLC | 1 | $26 |
| Eisai Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,711 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $1,975 |
| Gabapentin | 36 | $878 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $694 |
| Oxycodone Hcl | 29 | $650 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $533 |
| Rosuvastatin Calcium | 11 | $393 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $349 |
| Atorvastatin Calcium | 23 | $292 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $231 |
| Cyclobenzaprine Hcl | 22 | $223 |
| Alendronate Sodium | 28 | $210 |
| Alprazolam | 26 | $209 |
| Levothyroxine Sodium | 18 | $196 |
| Omeprazole | 13 | $140 |
| Methocarbamol | 16 | $125 |
Paid to pharmacies, not to this prescriber.
Other general practice in San Juan
- Gregorio Cortes-MaisonetSan Juan$12.8M
- Orvil MartinezSan Juan$211K
- Yudit Brito PequeroSan Juan$156K
- Miguel Sosa PadillaSan Juan$155K
- Vivian Tamayo AgraitSan Juan$96K
- William E TorresSan Juan$86K
- Roberto Unda GomezSan Juan$79K
- Eduardo Miralles AlonsoSan Juan$71K
- Victor PalmerSan Juan$21K
- Jose Davila SanchezSan Juan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.